Apimeds Pharmaceuticals US, Inc. (AMEX:APUS) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Elona Kogan Other companies: Seer, Inc. (CHIEF LEGAL OFFICER · Dec 3, 2020 – Feb 6, 2024 · Past); Cartesian Therapeutics, Inc. (General Counsel · Mar 20, 2019 – Jan 2, 2020 · Past); Ariad Pharmaceuticals Inc (Sr. V. P. - General Counsel · Jul 15, 2016 – Feb 16, 2017 · Past) | Director · Since at least Mar 4, 2025 |
| Bennett Weintraub | Director · Since at least Mar 25, 2026 |
| Brian Peters | Senior Vice President, ai² Division · Since at least Nov 10, 2025 |
| Carol O’Donnell | Director · Since at least Mar 25, 2026 |
| Christopher Kim | Chief Scientific Officer · Since at least Nov 5, 2026 |
| Eric Sherb | Chief Financial Officer · Since at least Nov 5, 2026 |
| Erik C Emerson | Chief Executive Officer, Director · Since at least Mar 4, 2025 |
| Hankil Yoon | Director · Since at least Mar 4, 2025 |
| Jakap Koo | Director · Since at least Mar 4, 2025 |
| Sungjoon Chae | Co-Chief Executive Officer · Since at least May 5, 2026 |
| Susan Kramer | Senior Vice President, Development · Since at least Jul 15, 2025 |
| Vin Menon | Chief Executive Officer and Director · Since at least Nov 3, 2026 |